ChemTalk is actively growing our advisory board and board of directors. Contact us if you are interested.
Prof John J Mieyal
Interim Chairman & Emeritus Professor, Department of Pharmacology, Case Western Reserve University
Dr. Mieyal is recognized internationally for advancing knowledge of redox regulation and signal transduction in health and disease, especially involving the glutaredoxin and thioredoxin enzyme systems. Professor Mieyal has been a featured speaker at many international symposia on Redox Regulation and Thiol Homeostasis in recent years, including those sponsored by the American Society of Biochemistry and Molecular Biology, the International Redox Network, and the International Gordon Conferences. He has served on scientific review boards for the National Institutes of Health, the American Heart Association, and the Department of Veterans Affairs; and he recently was guest editor for a special Forum Issue of the premier journal Antioxidants and Redox Regulation.
Besides recognition for his research, Dr. Mieyal has won several University awards for his medical and graduate school teaching and mentorship, most recently the first annual Inamori Award for Excellence in Mentoring, and he has served on the Pharmacology Committee of the National Board of Medical Examiners.
Assistant Professor of Chemistry, Pennsylvania State University
Lauren received her undergraduate degree at the University of Pennsylvania, and her PhD in chemistry from Harvard University. She currently runs the Zarzar Lab at Pennsylvania State University, focusing on studying stimuli-responsive materials, understanding the behavior of active matter, and developing laser fabrication methods to synthesize and pattern both inorganic and organic materials. Lauren is passionate about supporting women in science and science communication.
CEO, EMS Acquisition Holdings
|Michael Sobolewski is an accomplished Senior Executive and Board Member with more than 25 years of success across the aerospace & defense, medical device, industrial, commercial and IoT industries.|
Throughout his executive career, Michael has held Senior leadership positions at public, private and private equity companies including Sparton Corporation, CTS Corporation, Conelec, Be Green Packaging, WET Design and GDM Electronic & Medical.
Michael is currently the CEO of EMS Acquisition Holdings Inc, a Private Equity backed company building a national platform of companies in the Electronics Manufacturing Services market space.
Michael holds a BS In Aerospace Engineering and a BS in Mechanical Engineering from State University of New York (SUNY) at Buffalo and an MBA from the University of Central Florida. He was recently recognized in the San Fernando Valley, CA “Valley 200” list as one of the most influential leaders in the region. Michael resides in Newbury Park, CA with his family who all enjoy playing golf, mountain biking, hiking, and saltwater fishing together.
Dr. Zdeněk Pilat
Scientist, Czech Academy of Sciences
Zdeněk, a researcher from the Czech Republic, has been fascinated by science, particularly the beauties of experimental chemistry and physics, since childhood. He studied the molecular biology of plants at the Charles University in Prague, followed by a postgraduate study of physical engineering at the Technical University in Brno.
Zdeněk works in the Institute of Scientific Instruments of the Czech Academy of Sciences in Brno. He is pushing the frontier of knowledge in chemistry, biology, and medicine by developing cutting-edge analytical methods involving Raman micro-spectroscopy, optical tweezers, and microfluidics. He also supervises students, speaks at conferences, publishes scientific articles, and has received multiple young scientist awards. In his spare time, Zdeněk enjoys popularizing science, making YouTube videos of chemical experiments, playing guitar, painting, observing nature and stargazing.
Program Coordinator, KPM-Accelerate
Sebastian started his career by founding a chemical technology company out
of the University of Waterloo. Following the company’s exit, he turned his
attention to bridging the gap between the research/incubation and
commercialization for deep-tech companies. Now, as the leader of
KPM-Accelerate, he works to accelerate chemical technology start-ups by
integrating technical development, at the lab and pilot scale, with business
strategy and financial modeling. His other roles as an investor, board
member, and business architect allow him to help chem-tech start-ups at any
stage of their development bring the most impactful solutions to market.